Cargando…
Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022?
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187857/ https://www.ncbi.nlm.nih.gov/pubmed/37184515 http://dx.doi.org/10.1097/HC9.0000000000000117 |
_version_ | 1785042806091284480 |
---|---|
author | Wong, Jeffrey Sum Lung Leung, Roland Cheung, Tan To Yau, Thomas |
author_facet | Wong, Jeffrey Sum Lung Leung, Roland Cheung, Tan To Yau, Thomas |
author_sort | Wong, Jeffrey Sum Lung |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10187857 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-101878572023-05-17 Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022? Wong, Jeffrey Sum Lung Leung, Roland Cheung, Tan To Yau, Thomas Hepatol Commun Editorial Lippincott Williams & Wilkins 2023-05-15 /pmc/articles/PMC10187857/ /pubmed/37184515 http://dx.doi.org/10.1097/HC9.0000000000000117 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (https://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Editorial Wong, Jeffrey Sum Lung Leung, Roland Cheung, Tan To Yau, Thomas Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022? |
title | Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022? |
title_full | Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022? |
title_fullStr | Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022? |
title_full_unstemmed | Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022? |
title_short | Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022? |
title_sort | evolution of systemic therapy for advanced hcc patients: did we make progress in 2022? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187857/ https://www.ncbi.nlm.nih.gov/pubmed/37184515 http://dx.doi.org/10.1097/HC9.0000000000000117 |
work_keys_str_mv | AT wongjeffreysumlung evolutionofsystemictherapyforadvancedhccpatientsdidwemakeprogressin2022 AT leungroland evolutionofsystemictherapyforadvancedhccpatientsdidwemakeprogressin2022 AT cheungtanto evolutionofsystemictherapyforadvancedhccpatientsdidwemakeprogressin2022 AT yauthomas evolutionofsystemictherapyforadvancedhccpatientsdidwemakeprogressin2022 |